Needham & Company LLC Cuts Doximity (NYSE:DOCS) Price Target to $27.00

Posted by Stanley Muller on May 17th, 2026

Doximity (NYSE:DOCS – Free Report) had its target price cut by Needham & Company LLC from $55.00 to $27.00 in a research report released on Thursday, MarketBeat Ratings reports. They currently have a buy rating on the stock.

A number of other equities research analysts have also issued reports on DOCS. BMO Capital Markets set a $25.00 target price on shares of Doximity in a research note on Friday, February 6th. Barclays cut their target price on shares of Doximity from $63.00 to $38.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 11th. Royal Bank Of Canada restated an “outperform” rating and issued a $44.00 target price on shares of Doximity in a research note on Monday, March 9th. Truist Financial restated a “hold” rating and issued a $29.00 target price (down from $37.00) on shares of Doximity in a research note on Monday, April 20th. Finally, JPMorgan Chase & Co. cut their target price on shares of Doximity from $40.00 to $33.00 and set a “neutral” rating on the stock in a research note on Friday, February 20th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $30.62.

View Our Latest Stock Report on DOCS

Doximity Price Performance

Shares of DOCS stock opened at $18.93 on Thursday. Doximity has a 12 month low of $17.15 and a 12 month high of $76.51. The firm has a market cap of $3.50 billion, a price-to-earnings ratio of 19.12, a P/E/G ratio of 1.35 and a beta of 1.36. The business has a fifty day moving average price of $23.94.

Doximity announced that its Board of Directors has authorized a share repurchase plan on Thursday, February 5th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to buy up to 8% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s leadership believes its shares are undervalued.

Insider Transactions at Doximity

In related news, insider Siddharth Sitaram sold 2,309 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $25.77, for a total transaction of $59,502.93. Following the completion of the sale, the insider owned 89,396 shares of the company’s stock, valued at $2,303,734.92. This represents a 2.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $26.06, for a total transaction of $234,540.00. Following the sale, the director directly owned 19,839 shares of the company’s stock, valued at approximately $517,004.34. This represents a 31.21% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 18,055 shares of company stock valued at $456,061. Insiders own 31.30% of the company’s stock.

Institutional Investors Weigh In On Doximity

Institutional investors have recently modified their holdings of the business. Root Financial Partners LLC bought a new stake in shares of Doximity during the 3rd quarter valued at about $30,000. Whittier Trust Co. of Nevada Inc. grew its position in shares of Doximity by 59.5% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company’s stock valued at $35,000 after buying an additional 179 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in Doximity by 99.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after purchasing an additional 397 shares during the last quarter. Toth Financial Advisory Corp grew its position in Doximity by 100.0% in the 4th quarter. Toth Financial Advisory Corp now owns 1,000 shares of the company’s stock worth $44,000 after purchasing an additional 500 shares during the last quarter. Finally, Atlantic Union Bankshares Corp grew its position in Doximity by 136.9% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 616 shares of the company’s stock worth $45,000 after purchasing an additional 356 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

More Doximity News

Here are the key news stories impacting Doximity this week:

Positive Sentiment: Doximity said revenue still grew year over year, and its earnings call highlighted strong engagement from AI tool adoption, suggesting the platform is gaining traction with physicians. Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
Positive Sentiment: Doximity announced a partnership with Aledade to bring clinical AI tools into value-based care workflows, which could support longer-term adoption and monetization. DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
Neutral Sentiment: Several articles noted the stock has become technically oversold after a sharp selloff, which could set up a bounce if sentiment improves. Down 25.7% in 4 Weeks, Here’s Why Doximity (DOCS) Looks Ripe for a Turnaround
Negative Sentiment: Doximity missed quarterly earnings estimates and issued fiscal 2027 revenue guidance below Wall Street expectations, raising concerns that growth is slowing. Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript
Negative Sentiment: Analysts turned more cautious, with multiple firms cutting price targets or downgrading the stock, including Baird, Wells Fargo, BTIG, JPMorgan, Mizuho, BMO, Needham and Truist. DOCS vs. HIMS: Which Stock Is the Better Value Option?
Negative Sentiment: Investor caution also increased after insider selling was disclosed, even though it was tied to a pre-arranged 10b5-1 plan and tax withholding. Doximity (NYSE:DOCS) Insider Siddharth Sitaram Sells 2,309 Shares

Doximity Company Profile

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.